Medicus Pharma Ltd. Files 6-K Report
Ticker: MDCXW · Form: 6-K · Filed: Dec 2, 2024 · CIK: 1997296
Sentiment: neutral
Topics: disclosure, regulatory-filing, press-release
TL;DR
Medicus Pharma filed a 6-K on Dec 2nd, likely with a press release. Keep an eye out for news.
AI Summary
Medicus Pharma Ltd. filed a Form 6-K on December 2, 2024, to report a press release dated the same day. The company, incorporated in Canada and operating in the Pharmaceutical Preparations sector, is headquartered at 100 King Street West, Suite 3400, Toronto, Ontario, M5X 1A4. Dr. Raza Bokhari signed the filing on behalf of Medicus Pharma Ltd.
Why It Matters
This filing indicates that Medicus Pharma Ltd. is providing updated information or making an announcement to the SEC, which could be material to investors.
Risk Assessment
Risk Level: low — A 6-K filing is typically for routine disclosures and does not inherently signal high risk.
Key Numbers
- 001-42408 — SEC File Number (Identifies the company's filing history with the SEC)
Key Players & Entities
- Medicus Pharma Ltd. (company) — Filer of the report
- December 2, 2024 (date) — Date of the report and press release
- Dr. Raza Bokhari (person) — Signed the filing on behalf of the company
- 100 King Street West, Suite 3400, Toronto, Ontario, M5X 1A4 (location) — Principal executive office address
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K filing is to report a press release dated December 2, 2024, as required by the SEC.
Who signed the Form 6-K on behalf of Medicus Pharma Ltd.?
Dr. Raza Bokhari signed the Form 6-K on behalf of Medicus Pharma Ltd.
What is the principal executive office address of Medicus Pharma Ltd.?
The principal executive office address is Suite 3400, 100 King Street West, Toronto, Ontario, Canada, M5X 1A4.
What is the SIC code for Medicus Pharma Ltd.?
The Standard Industrial Classification (SIC) code for Medicus Pharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Does Medicus Pharma Ltd. file annual reports under Form 20-F or 40-F?
Medicus Pharma Ltd. indicated that it files annual reports under cover of Form 20-F.
Filing Stats: 164 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2024-12-02 10:00:13
Filing Documents
- form6k.htm (6-K) — 6KB
- exhibit99-1.htm (EX-99.1) — 11KB
- exhibit99-1x001.jpg (GRAPHIC) — 10KB
- 0001062993-24-019855.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicus Pharma Ltd. Date: December 2, 2024 By /s/ Raza Bokhari Name: Dr. Raza Bokhari Title: Executive Chairman and Chief Executive Officer